Bill Snyder

September 18, 2014

Initiative seeks to develop therapies to combat Ebola

Vanderbilt University researchers have partnered with Mapp Biopharmaceutical Inc. to develop new human antibody therapies for people exposed to the deadly Ebola and Marburg viruses.

By Bill Snyder
September 12, 2014

Schizophrenia ‘switches’ discovered

Drugs developed at Vanderbilt could provide a new way to treat schizophrenia in a personalized way.

By Bill Snyder
September 11, 2014

Meeting explores VUMC’s cultural renaissance

During presentations that were filled with messages about Vanderbilt University Medical Center’s purpose, addressing the “why” rather than detailing facts and figures, Jeff Balser, M.D., Ph.D., vice chancellor for Health Affairs and dean of the School of Medicine, and C. Wright Pinson, MBA, M.D., deputy vice chancellor for Health Affairs and CEO of the Vanderbilt Health System, led the audience at Wednesday’s Fall Leadership Assembly through candid dialogue about VUMC’s way forward.

By Bill Snyder
A smiling woman in her 50s in front of a rock wall.
September 11, 2014

Study tracks new way to fight HIV infection in women

Vanderbilt University’s Richard Caprioli, Ph.D., is participating in a national, federally funded collaboration to develop an intravaginal ring capable of delivering antiretroviral drugs to women at risk for HIV infection.

By Bill Snyder
neuron
September 4, 2014

Foundation grants bolster autism, dystonia research

Vanderbilt University researchers have received multi-year grants from two private foundations to investigate key signaling proteins that could lead to novel treatments for autism spectrum disorder (ASD) and dystonia, a movement disorder.

By Bill Snyder
September 4, 2014

Science educations bloom from ‘Simple Beginnings’

Vanderbilt University welcomed 99 new doctoral students last Friday, Aug. 29, during the fifth annual “Simple Beginnings” ceremony in a Light Hall lecture room packed with family members and other well-wishers.

By Bill Snyder
August 28, 2014

Diverse lineup set for Discovery Lecture series

Richard J. Smith, M.D., director of the Molecular Otolaryngology and Renal Research Laboratories (MORL) at the University of Iowa Carver College of Medicine, will begin the 2014-2015 Flexner Discovery Lecture Series on Thursday, Sept. 11.
By Bill Snyder
August 28, 2014

Ascano seeks to shed light on cellular stress response

Ebola. Chikungunya. Influenza. What’s to be done about these headline-grabbing, debilitating, often lethal viruses?
By Bill Snyder
August 21, 2014

Major grant spurs deeper look into ‘good cholesterol’

In some cases, HDL, the "good cholesterol," may not function properly and may actually accelerate atherosclerosis.
By Bill Snyder
August 21, 2014

New technique accelerates genome editing process

It sounds like a potato chip. But CRISPR is actually the acronym for a new genome editing technique that, by many accounts, is accelerating the study of genes and disease.
By Bill Snyder
August 14, 2014

Team takes 4-D look at brain receptor’s role

Reporting last week in the journal Cell, researchers from Oregon Health and Science University, Harvard Medical School and Vanderbilt University describe the first “four-dimensional” picture of a brain receptor that plays a key role in learning and memory.
By Bill Snyder
August 7, 2014

Conn lands Javits Neuroscience Investigator award

Vanderbilt University’s P. Jeffrey Conn, Ph.D., has won a Javits Neuroscience Investigator Award from the National Institute of Neurological Disorders and Stroke for discoveries that could lead to new treatments for anxiety, schizophrenia and other brain disorders.
By Bill Snyder
1 … 92 93 94 95 96 … 115